AXSM
Axsome Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$206.68
−0.80%Leverage
- Debt / equity
- 2.63x
- Net debt / equity
- -1.21x
- Debt / assets
- 0.29x
- Debt / EBITDA
- -1.22x
- Net debt / EBITDA
- 0.56x
Liquidity & coverage
- Current ratio
- 1.43x
- Quick ratio
- 1.34x
- Cash ratio
- 0.69x
- Interest coverage
- -37.58x
- EBITDA / interest
- -35.84x
- Working capital
- $196.1M
Cash & dividend
- FCF / debt
- -0.33x
- Cash flow / debt
- -0.33x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026